RIGEL PHARMACEUTICALS INC 4
4 · RIGEL PHARMACEUTICALS INC · Filed Jul 7, 2017
Insider Transaction Report
Form 4
Duliege Anne-Marie
Chief Medical Officer
Transactions
- Sale
Common Stock
2017-07-05$2.69/sh−5,000$13,427→ 0 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 10, 2016.
- [F2]The Reporting Person purchased these shares on 6/30/17 under the Employee Stock Purchase Plan.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.65 to $2.75, inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price within the range set forth in footnote three (3) of this Form 4.